Latest News

US drug agency to fund further testing of Solvonis addiction candidate
Solvonis Therapeutics PLC (LSE:SVNS, OTC:SLVNF) has cleared the first hurdle in a US government testing programme for an experimental treatment for cocaine and methamphetamine addiction. The National

Diversified Energy turns driller in shift away from acquisition-led growth
Diversified Energy Company PLC (LSE:DEC, NYSE:DEC, FRA:DG20), the Alabama-based gas producer listed in London and New York, is to start drilling its own wells, a departure from the acquisition-led mod

SoundHound AI, Inc. (SOUN) Q2 2026 Earnings Call Transcript
SoundHound AI, Inc. (SOUN) Q2 2026 Earnings Call Transcript

Evotec and Odyssey Therapeutics Enter AI-Enabled R&D Collaboration in Autoimmune and Inflammatory Diseases
Collaboration combines Odyssey's disease biology expertise with Evotec's AI-enabled discovery platform, advanced screening capabilities and proprietary compound libraries to support advancement of Ody

RxSight, Inc. (RXST) Q2 2026 Earnings Call Transcript
RxSight, Inc. (RXST) Q2 2026 Earnings Call Transcript

Eli Lilly Q2: Strong Results Further Strengthen The Investment Thesis
Eli Lilly remains a buy after Q2, with robust revenue growth and strong performance from Mounjaro and Zepbound. LLY raised 2026 revenue guidance to $85–87 billion, driven by volume gains despite price

Google is expanding its AI empire — and losing the people who built it
Google's cloud boom is testing the company's commitment to frontier AI as commercial returns take priority. Jeff Dean's departure and Demis Hassabis' move away from daily management of DeepMind add to

ONE Group Hospitality Q2 Earnings Call Highlights
ONE Group Hospitality NASDAQ: STKS reported second-quarter revenue declined from a year earlier, as planned restaurant portfolio optimization and a delayed New York City relocation weighed on reported

Symbotic Q3 Earnings Call Highlights
Symbotic NASDAQ: SYM reported fiscal third-quarter 2026 revenue of $721 million, up 22% from a year earlier and 7% sequentially, as the warehouse automation company expanded system deployments and gre

TaskUs Q2 Earnings Call Highlights
TaskUs NASDAQ: TASK reported second-quarter 2026 revenue of $308.9 million, up 5% from a year earlier and $10.9 million above the high end of its prior guidance, as growth in AI Services and Digital C

ThredUp Q2 Earnings Call Highlights
ThredUp NASDAQ: TDUP reported second-quarter 2026 revenue of $90.8 million, up 16.9% from a year earlier, as active buyers and orders grew at double-digit rates. The online resale company said the res

Alpha Teknova Q2 Earnings Call Highlights
Alpha Teknova NASDAQ: TKNO reported second-quarter revenue growth of 18% from a year earlier, surpassing $12 million for its highest quarterly revenue in the company's 30-year history. The company rai

biote Corp. (BTMD) Q2 2026 Earnings Call Transcript
biote Corp. (BTMD) Q2 2026 Earnings Call Transcript

Envista Holdings Corporation (NVST) Q2 2026 Earnings Call Transcript
Envista Holdings Corporation (NVST) Q2 2026 Earnings Call Transcript

Pacific Biosciences: It's Only Getting Worse
Pacific Biosciences reported Q2 revenues of $39.01 million, missing estimates and guiding 2026 revenues down, below consensus. Operating and net losses remain sizable, with cash now under $237 million

Pizza Pizza Royalty Corp. (PZA:CA) Q2 2026 Earnings Call Transcript
Pizza Pizza Royalty Corp. (PZA:CA) Q2 2026 Earnings Call Transcript

Pacific Biosciences of California, Inc. (PACB) Q2 2026 Earnings Call Transcript
Pacific Biosciences of California, Inc. (PACB) Q2 2026 Earnings Call Transcript

Clearway Energy, Inc. (CWEN) Q2 2026 Earnings Call Transcript
Clearway Energy, Inc. (CWEN) Q2 2026 Earnings Call Transcript

Amadeus FiRe AG (AFGZF) Q2 2026 Earnings Call Transcript
Amadeus FiRe AG (AFGZF) Q2 2026 Earnings Call Transcript

Amkor Technology's Valuation Lags Its Growth
Amkor Technology is rated Strong Buy, with record Q2 2026 performance and robust multi-year growth drivers from AI and advanced packaging. Q2 revenue surged 26% YoY to $1.90B, gross margin improved to